Healthcare, especially Pharma, has undervalued the importance of diverse representation in clinical trials. Now there’s a deficit in science as America becomes more diverse.
Healthcare, especially Pharma, has undervalued the importance of diverse representation in clinical trials. Now there’s a deficit in science as America becomes more diverse.